|
CRVO CervoMed Inc 1053691 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,964,158.00 |
| Balance Sheet |
|
Current Assets
|
$15,112,918.00 |
|
Assets
|
$15,112,918.00 |
|
Current Liabilities
|
$4,656,117.00 |
|
Liabilities
|
$4,497,203.00 |
|
Equity
|
$10,615,715.00 |
|
Shares Out
|
9258719.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-8,018,338.00 |
|
Investing Cash Flow
|
$7,710,820.00 |
| Market Analysis |
Market Cap
|
$23,331,971.88 |
|
Price
|
$2.65 |
|
BVPS
|
1.15 |
|
PB
|
2.19 |
|
EPS
|
-0.86 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:41 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:41 |
|
| Apr |
May |
Jun |
| 2026-03-13 |
-2.98 |
|
|
2026-05-18 |
|
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-07 |
-0.84 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CRVO documents filed with the SEC.
CRVO Filings
Clear
